Luciano Racco is mentioned in a FirstWord Pharma article titled “ViewPoints: Cross-Border Deals Still Worth the Risk Despite Rising US-China Tensions.”
LINKS
Read “ViewPoints: Cross-Border Deals Still Worth the Risk Despite Rising US-China Tensions.” (subscription)